Skip to main content
. 2018 May 11;2018(5):CD011883. doi: 10.1002/14651858.CD011883.pub2

1.42. Analysis.

Comparison 1 Antipsychotic dose increase versus antipsychotic dose maintenance, Outcome 42 Adverse effects ‐ Extrapyramidal: average endpoint score (SAS, high = poor).